APDS | Letteratura scientifica

ASH PUBLICATION
BLOOD - PLENARY PAPER| MARCH 2, 2023

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

V. Koneti Rao, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina, Niall Conlon, Tanya Coulter, Virgil A. Dalm, Antonino Trizzino, Yulia Zharankova, Elaine Kulm, Julia Körholz, Vassilios Lougaris, Yulia Rodina, Kath Radford, Jason Bradt, Klaus Kucher, Anurag Relan, Steven M. Holland, Michael J. Lenardo, Gulbu Uzel

ITALIAN JOURNAL OF PEDIATRICS
REWIEW (2024)

Activated phosphoinositde 3-kinase (PI3Kδ) syndrome: an Italian point of view on diagnosis and new advances in treatment

Vassilios Lougaris¹, Federico Le Piane², Caterina Cancrini^3,4, Francesca Conti⁵, Alberto Tommasini^6,7, Raffaele Badolato⁸, Antonino Trizzino⁹, Marco Zecca¹⁰, Antonio De Rosa¹¹, Federica Barzaghi¹² and Claudio Pignata^11*

EAACI CONGRESS 2024
POSTER TPS44

Rapid clinical and immunological improvement of persistent lymphoproliferative disease in a patient with activated PI3K delta syndrome (APDS1)

Beatrice Rivalta¹, Silvia Di Cesare^1,2, Lucia Pacillo¹, Cristina Cifaldi^1,2, Gigliola Di Matteo^1,2, Luciana Vinti¹, Paolo Palma^1,2, Giuseppe Palumbo^1,2, Veronica Santilli¹, and Caterina Cancrini^1,2